Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
366
-
Total 13F shares, excl. options
-
35.8M
-
Shares change
-
-254K
-
Total reported value, excl. options
-
$7.85B
-
Value change
-
-$46M
-
Put/Call ratio
-
0.69
-
Number of buys
-
166
-
Number of sells
-
-142
-
Price
-
$219.51
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q4 2019
393 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q4 2019.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 366 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.8M shares
of 152M outstanding shares and own 23.49% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.81M shares), VANGUARD GROUP INC (3.57M shares), BROWN CAPITAL MANAGEMENT LLC (1.64M shares), WELLINGTON MANAGEMENT GROUP LLP (1.63M shares), BAMCO INC /NY/ (1.53M shares), Neuberger Berman Group LLC (1.39M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.35M shares), JANUS HENDERSON GROUP PLC (1.22M shares), Invesco Ltd. (1.04M shares), and Mairs & Power INC (1M shares).
This table shows the top 366 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.